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Abstract
Plasmode is a term coined several years ago to describe data sets that are derived from real data but for which some truth is
known. Omic techniques, most especially microarray and genomewide association studies, have catalyzed a new zeitgeist of
data sharing that is making data and data sets publicly available on an unprecedented scale. Coupling such data resources
with a science of plasmode use would allow statistical methodologists to vet proposed techniques empirically (as opposed
to only theoretically) and with data that are by definition realistic and representative. We illustrate the technique of
empirical statistics by consideration of a common task when analyzing high dimensional data: the simultaneous testing of
hundreds or thousands of hypotheses to determine which, if any, show statistical significance warranting follow-on
research. The now-common practice of multiple testing in high dimensional experiment (HDE) settings has generated new
methods for detecting statistically significant results. Although such methods have heretofore been subject to comparative
performance analysis using simulated data, simulating data that realistically reflect data from an actual HDE remains a
challenge. We describe a simulation procedure using actual data from an HDE where some truth regarding parameters of
interest is known. We use the procedure to compare estimates for the proportion of true null hypotheses, the false
discovery rate (FDR), and a local version of FDR obtained from 15 different statistical methods.
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Introduction
‘‘Omic’’ technologies (genomic, proteomic, etc.) have led to
high dimensional experiments (HDEs) that simultaneously test
thousands of hypotheses. Often these omic experiments are
exploratory, and promising discoveries demand follow-up labora-
tory research. Data from such experiments require new ways of
thinking about statistical inference and present new challenges.
For example, in microarray experiments an investigator may test
thousands of genes aiming to produce a list of promising
candidates for differential genetic expression across two or more
treatment conditions. The larger the list, the more likely some
genes will prove to be false discoveries, i.e. genes not actually
affected by the treatment.
Statistical methods often estimate both the proportion of tested
genes that are differentially expressed due to a treatment condition
and the proportion of false discoveries in a list of genes selected for
follow-up research. Because keeping the proportion of false
discoveries small ensures that costly follow-on research will yield
more fruitful results, investigators should use some statistical
method to estimate or control this proportion. However, there is
no consensus on which of the many available methods to use [1].
How should an investigator choose?
Although the performance of some statistical methods for
analyzing HDE data has been evaluated analytically, many
methods are commonly evaluated using computer simulations.
An analytical evaluation (i.e., one using mathematical derivations
to assess the accuracy of estimates) may require either difficult-to-
verify assumptions about a statistical model that generated the
data or a resort to asymptotic properties of a method. Moreover,
for some methods an analytical evaluation may be mathematically
intractable. Although evaluations using computer simulations may
overcome the challenge of intractability, most simulation methods
still rely on the assumptions inherent in the statistical models that
generated the data. Whether these models accurately reflect reality
is an open question, as is how to determine appropriate
parameters for the model, what realistic ‘‘effect sizes’’ to
incorporate in selected tests, as well as if and how to incorporate
correlation structure among the many thousands of observations
per unit [2].
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challenges inherent in generating realistic simulated data sets. Catell
and Jaspers [3] made early use of the term when they defined a
plasmode as ‘‘a set of numerical values fitting a mathematico-
theoretical model.That it fits the model may be known either because
simulated data is produced mathematically to fit the functions, or
because we have a real—usually mechanical—situation which we
k n o ww i t hc e r t a i n t ym u s tp r o d u c ed a t ao ft h a tk i n d . ’ ’M e h t ae ta l .
(p. 946) [2] more concisely refer to a plasmode as ‘‘a real data set
whose true structure is known.’’ The plasmodes can accommodate
unknown correlation structures among genes, unknown distributions
of effects among differentially expressed genes, an unknown null
distribution of gene expression data, and other aspects that are
difficult to model using theoretical distributions. Not surprisingly, the
use of plasmode data sets is gaining traction as a technique of
simulating reality-based data from HDEs [4].
A plasmode data set can be constructed by spiking specific
mRNAs into a real microarray data set [5]. Evaluating whether a
particular method correctly detects the spiked mRNAs provides
information about the method’s ability to detect gene expression.
A plasmode data set can also be constructed by using a current
data set as a template for simulating new data sets for which some
truth is known. Although in early microarray experiments, sample
sizes were too small (often only 2 or 3 arrays per treatment
condition) to use as a basis for a population model for simulating
data sets, larger HDE data sets have recently become publicly
available, making their use feasible for simulation experiments.
In this paper, we propose a technique to simulate plasmode data
sets from previously produced data. The source-data experiment
was conducted at the Center for Nutrient–Gene Interaction
(CNGI, www.uab.edu/cngi), at the University of Alabama at
Birmingham. We use a data set from this experiment as a template
for producing a plasmode null data set, and we use the distribution
of effect sizes from the experiment to select expression levels for
differentially expressed genes. The technique is intuitively
appealing, relatively straightforward to implement, and can be
adapted to HDEs in contexts other than microarray experiments.
We illustrate the value of plasmodes by comparing 15 different
statistical methods for estimating quantities of interest in a
microarray experiment, namely the proportion of true nulls
(hereafter denoted p0), the false discovery rate (FDR) [6] and a
local version of FDR (LFDR) [7]. This type of analysis enables us,
for the first time, to compare key omics research tools according to
their performance in data that, by definition, are realistic
exemplars of the types of data biologists will encounter. The
illustrations given here provide some insight into the relative
performance characteristics of the 15 methods in some circum-
stances, but definitive claims regarding uniform superiority of one
method over another would require more extensive evaluations
over multiple types of data sets.
Results
Simulation Design – Producing the Plasmode Data Sets
Steps for plasmode creation that are described herein are
relatively straightforward. First, an HDE data set is obtained that
reflects the type of experiment for which statistical methods will be
used to estimate quantities of interest. Data from a rat microarray
experiment at CNGI were used here. Other organisms might
produce data with different structural characteristics and methods
may perform differently on such data. The CNGI data were
obtained from an experiment that used rats to test the pathways
and mechanisms of action of certain phytoestrogens [8,9]. In brief,
rats were divided into two large groups, the first sacrificed at day
21 (typically the day of weaning for rats), the second sacrificed at
day 50 (the day, corresponding to late human puberty, when rats
are most susceptible to chemically induced breast cancer). Each of
these groups was subdivided into smaller groups according to diet.
At 21 and 50 days, respectively, the relevant tissues from these rat
groups were appropriately processed, and gene expression levels
were extracted using GCOS (GeneChip Operating Software). We
exported the microarray image (*.CEL) files from GCOS and
analyzed them with the Affymetrix Package of Bioconductor/R to
extract the MAS 5.0 processed expression intensities. The arrays
and data were investigated for outliers using Pearson’s correlation,
spatial artifacts [10] and a deleted residuals approach [11]. It is
important to note that only one normalization method was
considered, but the methods could be compared on RMA
normalized data as well. In fact, comparisons of methods’
performances on data from different normalization techniques
could be done using the plasmode technique.
Second, an HDE data set that compares effect of a treatment(s) is
analyzed and the vector of effect sizes is saved. The effect size used
herewasa simple standardized mean difference(i.e., a twosample t-
statistics) but any meaningful metric could be used. Plasmodes, in
fact, could be used to compare the performance of statistical
methods when different statistical tests were used to produce the P-
values.WechosetwosetsofHDEdataastemplatestorepresenttwo
distributions of effect sizes and two different null distributions. We
refer to the 21-day experiment using the control group (8 arrays)
and the treatment group (EGCG supplementation, 10 arrays) as
data set 1, and the 50-day experiment using the control group (10
arrays) and the treatment group (Resveratrol supplementation, 10
arrays) as data set 2. There were 31,042 genes on each array, and
two sample pooled variance t-tests for differential expression were
used to create a distribution of P-values. Histograms of the
distributions for both data sets are shown in Figure 1.
The distribution of P-values for data set 1 shows a stronger
signal (i.e., a larger collection of very small P-values) than that for
data set 2, suggesting either that more genes are differentially
expressed or that those that are expressed have a larger magnitude
treatment effect. This second step provided a distribution of effects
sizes from each data set.
Author Summary
Plasmode is a term used to describe a data set that has
been derived from real data but for which some truth is
known. Statistical methods that analyze data from high
dimensional experiments (HDEs) seek to estimate quanti-
ties that are of interest to scientists, such as mean
differences in gene expression levels and false discovery
rates. The ability of statistical methods to accurately
estimate these quantities depends on theoretical deriva-
tions or computer simulations. In computer simulations,
data for which the true value of a quantity is known are
often simulated from statistical models, and the ability of a
statistical method to estimate this quantity is evaluated on
the simulated data. However, in HDEs there are many
possible statistical models to use, and which models
appropriately produce data that reflect properties of real
data is an open question. We propose the use of
plasmodes as one answer to this question. If done
carefully, plasmodes can produce data that reflect reality
while maintaining the benefits of simulated data. We show
one method of generating plasmodes and illustrate their
use by comparing the performance of 15 statistical
methods for estimating the false discovery rate in data
from an HDE.
Evaluating Methods with Plasmodes
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data sets, we created a random division of the control group of
microarrays into two sets of equal size. One consideration in doing
so is that if some arrays in the control group are ‘different’ from
others due to some artifact in the experiment, then the null data
set can be sensitive to how the arrays are divided into two sets.
Such artifacts can be present in data from actual HDEs, so this
issue is not a limitation of plasmode use but rather an attribute of
it, that is, plasmodes are designed to reflect actual structure
(including artifacts) in a real data set. We obtained the plasmode
null data set from data set 1 by dividing the day 21 control group
of 8 arrays into two sets of 4, and for data set 2 by dividing the
control group of 10 arrays into two sets of 5 arrays. Figure 2 shows
the two null distributions of P-values obtained using the two
sample t-test on the plasmode null data sets. Both null distributions
are, as expected, approximately uniform, but sampling variability
allows for some deviation from uniformity.
A proportion 12p0 of effect sizes were then sampled from their
respective distributions using a weighted probability sampling
technique described in the Methods section. What sampling
probabilities are chosen can be a tuning parameter in the
plasmode creation procedure. The selected effects were incorpo-
rated into the associated null distribution for a randomly selected
proportion 12p0 of genes in a manner also described in the
Methods section. What proportion of genes is selected may depend
upon how many genes in an HDE are expected to be differentially
expressed. This may determine whether a proportion equal to 0.01
or 0.5 is chosen to construct a plasmode. Proportions between 0.05
and 0.2 were used here as they are in the range of estimated
proportions of differentially expressed genes that we have seen
from the many data sets we have analyzed.
Finally, the plasmode data set was analyzed using a selected
statistical method. We used two sample t-tests to obtain a
plasmode distribution of P-values for each plasmode data set
because the methods compared herein all analyze a distribution of
P-values from an HDE. P-values were declared statistically
significant if smaller than a threshold t. Box 1 summarizes symbol
definitions.
When comparing the 15 statistical methods, we used three values
of p0 (0.8, 0.9, and 0.95) and two thresholds (t=0.01 and 0.001).
For each choice of p0 and threshold t, we ran B=100 simulations.
All 15 methods provided estimates of p0, 14 provided estimates of
FDR, and 7 provided estimates of LFDR. Because the true values of
p0 and FDRareknown foreachplasmode data set,we cancompare
the accuracy of estimates from the different methods.
Methods for Estimating FDR
There are two basic strategies for estimating FDR, both
predicated on an estimated value for p0, the first using
equation (1) below, the second using a mixture model approach.
Figure 1. Distribution of P-values from tests for differential expression for the two data sets. P-values were computed from the original
data using two sample pooled variance t-tests.
doi:10.1371/journal.pgen.1000098.g001
Box 1: Notation for parameters used in modeling high
dimensional data
p0=A true proportion of genes for which there is no
differential expression. This value is controlled by the
experimenter in a simulation study.
12p0=the proportion of genes that are truly differentially
expressed.
p ˆ0=An estimate of p0 obtained using a statistical method
on data from an HDE.
t=A threshold set by the investigator below which P-
values are declared statistically significant.
Evaluating Methods with Plasmodes
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significant at a given threshold, where M and K were defined with
respect to quantities in Table 1. Then one estimate for FDR at this
threshold is,
d FDR FDR~
^ p p0t
PK
ð1Þ
The mixture model (usually a two-component mixture) approach
uses a model of the form,
fp ;p0,h ðÞ ~p0f0 p ðÞ z 1{p0 ðÞ f1 p ðÞ ð 2Þ
where f is a density, p represents a P-value, f0 a density of a P-value
under the null hypothesis, f1 a density of a P-value under the
alternative hypothesis, p0 is interpreted as before, and h a (possibly
vector) parameter of the distribution. Since valid P-values are
assumed, f0 is a uniform density. LFDR is defined with respect to
this mixture model as,
LFDR~
p0
p0z 1{p0 ðÞ f1 t ðÞ
: ð3Þ
FDR is defined similarly except that the densities in (3) are
replaced by the corresponding cumulative distribution functions
(CDF), that is,
FDR~
p0t
p0tz 1{p0 ðÞ F1 t ðÞ
ð4Þ
where F1(t) is the CDF under the alternative hypothesis, evaluated
at a chosen threshold t. (There are different definitions of FDR
and the definition in (4) is, under some conditions, the definition of
a positive false discovery rate [12]. However, in cases with a large
number of genes many of the variants of FDR are very close [13]).
The methods are listed for quick reference in Table 2. Methods
1–8 use different estimates for p0 and, as implemented herein,
proceed to estimate FDR using equation (1). Method 9 uses a
unique algorithm to estimate LFDR and does not supply an
estimate of FDR. Methods 10–15 are based on a mixture model
framework and estimate FDR and LFDR using equations (3) and
(4) where the model components are estimated using different
techniques. All methods were implemented using tuning param-
eter settings from the respective paper or ones supplied as default
values with the code in cases where the code was published online.
Figure 2. Distribution of P-values for the two plasmode null data sets. P-values were computed from two sample pooled variance t-tests.
doi:10.1371/journal.pgen.1000098.g002
Table 1. Quantities of interest in microarray experiments.
Genes for which there is not a real effect Genes for which there is a real effect
Genes not declared significant at designated threshold AB
Genes declared significant at designated threshold CD
A+B+C+D=K=the number of genes analyzed in a microarray experiment. M=C+D is the number of rejected null hypotheses.
doi:10.1371/journal.pgen.1000098.t001
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First, to compare their differences, we used the 15 methods to
analyze the original two data sets, with data set 1 having a
‘‘stronger signal’’ (i.e., lower estimates of p0 and FDR). Estimates
of p0 from methods 3 through 15 ranged from 0.742 to 0.837 for
data set 1 and 0.852 to 0.933 for data set 2. (Methods 1 and 2 are
designed to control for rather than estimate FDR and are designed
to be conservative; hence, their estimates were much closer to 1.)
Results of these analyses can be seen in the Supplementary Tables
S1 and S2.
Next, using the two template data sets we constructed plasmode
data sets in order to compare the performance of the 15 methods
for estimating p0 (all methods), FDR (all methods except method
9), and LFDR (methods 9–15). Figures 3 and 4 show some results
based on data set 2. More results are available in the Figures S1,
S2, S3, S4, S5, and S6.
Figure 3 shows the distribution of 100 estimates for p0 using
data set 2 when the true value of p0 is equal to 0.8 and 0.9.
Methods 1 and 2 are designed to be conservative (i.e., true values
are overestimated). With a few exceptions, the other methods tend
to be conservative when p0=0.8 and liberal (the true value is
underestimated) when p0=0.9. The variability of estimates for p0
is similar across methods, but some plots show a slightly larger
variability for methods 12 and 15 when p0=0.9.
Figure 4 shows the distribution of estimates for FDR and LFDR
at the two thresholds. The horizontal lines in the plots show the
mean (solid line) and the minimum and maximum (dashed lines) of
the true FDR value for the 100 simulations. A true value for
LFDR is not known in the simulation procedure. The methods
tend to be conservative (overestimate FDR) when the threshold
t=0.01 and are more accurate at the lower threshold. Estimates of
FDR are more variable for methods 11, 13, and 14 and estimates
for LFDR more variable for methods 13 and 14, with the
exception of a few unusual estimates obtained from method 9. The
Table 2. Fifteen methods with the source of the software
used herein.
Method Citation Source of code
1 Benjamini and Hochberg [6] GeneTS
2 Benjamini and Hochberg [14] GeneTS
3 Mosig et al., [15] Website
4 Storey & Tibshirani [16] Qvalue
5 Storey, Taylor, Siegmund [17] Qvalue
6 Schweder and Spjøtvoll [18] Coded by us
7 Dalmasso, Broe ¨t, and Moreau [19] Author website
8 Langaas, Lindqvist, Ferkingstad [20] Limma
9 Scheid and Spang [21] Twilight
10 Pounds and Morris [22] Author website
11 Pounds and Cheng [23] Author website
12 Liao et al., [24] Author website
13 Broberg [25] SAGx
14 Broberg [25] SAGx
15 Allison et al., [26] From authors
Most software was available as an R library at www.r-project.org, and was
otherwise available from an author’s website or coded by us.
doi:10.1371/journal.pgen.1000098.t002
Figure 3. Boxplots for estimates of p0 from 100 plasmodes based on data set 2 for the 15 methods. Two cases are shown representing A.
p0=0.8 and B. p0=0.9, represented by the horizontal line in the two plots A and B, respectively.
doi:10.1371/journal.pgen.1000098.g003
Evaluating Methods with Plasmodes
PLoS Genetics | www.plosgenetics.org 5 June 2008 | Volume 4 | Issue 6 | e1000098high variability of FDR estimates from method 11 may be due to a
‘‘less than optimal’’ choice of the spanning parameter in a
numerical smoother (see also Pounds and Cheng [27]). We did not
attempt to tune any of the methods for enhanced performance.
Discussion
Researchers have been evaluating the performance of the
burgeoning number of statistical methods for the analysis of high
dimensional omic data, relying on a mixture of mathematical
derivations, computer simulations, and sadly, often single dataset
illustrations or mere ipse dixit assertions. Recognizing that the latter
two approaches are simply unacceptable approaches to method
validation [2] and that the first two suffer from limitations
described earlier, an increasing number of investigators are
turning to plasmode datasets for method evaluation [28]. An
excellent example is the Affycomp website (http://affycomp.
biostat.jhsph.edu/) that allows investigators to compare different
microarray normalization methods on datasets of known structure.
Other investigators have also recently used plasmode-like
approaches which they refer to as ‘data perturbation’ [29,30],
yet it is not clear that these ‘perturbed datasets’ can distinguish
true from false positives, suggesting greater need for articulation of
principles or standards of plasmode generation.
As more high dimensional experiments with larger sample sizes
become available, researchers can use a new kind of simulation
experiment to evaluate the performance of statistical analysis
methods, relying on actual data from previous experiments as a
template for generating new data sets, referred to herein as
plasmodes. In theory, the plasmode method outlined here will
enable investigators to choose on an empirical basis the most
appropriate statistical method for their HDEs.
Our results also suggest that large, searchable databases of
plasmode data sets would help investigators find existing data sets
relevant to their planned experiments. (We have already
implemented a similar idea for planning sample size requirements
in HDEs [31,32].) Investigators could then use those data sets to
compare and evaluate several analytical methods to determine
which best identifies genes affected by the treatment condition. Or,
investigators could use the plasmode approach on their own data
sets to glean some understanding of how well a statistical method
works on their type of data. Our results compare the performance
of 15 statistical methods as they process the specific plasmode data
sets constructed from the CNGI data. Although identifying one
uniformly superior method (if there is one) is difficult within the
limitations of this one comparison, our results suggest that certain
methods could be sensitive to tuning parameters or different types
of data sets. A comparison over multiple types of source data sets
Figure 4. Plots of estimated FDR (A and C) and LFDR (B and D) using the 15 methods in 100 plasmodes from data set 2 for the case
where p0=0.9. Estimates calculated at two thresholds t=0.01 (A and B) and 0.001 (C and D) are shown. For the plots of FDR estimates, the
horizontal line is the mean of the 100 true values of FDR in the plasmodes and the horizontal dashed lines are the minimum and maximum. True
values of LFDR are not known.
doi:10.1371/journal.pgen.1000098.g004
Evaluating Methods with Plasmodes
PLoS Genetics | www.plosgenetics.org 6 June 2008 | Volume 4 | Issue 6 | e1000098with different distributions of effects sizes could add the detail
necessary to clearly recommend certain methods over others [1].
Other papers have used simulation studies to compare the
performance of methods for estimating p0 and FDR (e.g., Hsueh et
al. [33]; Nguyen [34]; Nettleton et al. [35]). We compared
methods that use the distribution of P-values as was done in
Broberg [36] and Yang and Yang [37]. Unlike our plasmode
approach, most earlier comparison studies used normal distribu-
tions to simulate gene expression data and incorporated
dependence using a block diagonal correlation structure as in
Allison et al [26].
A key implication and recommendation of our paper is that, as
data from the growing number of HDEs is made publicly
available, researchers may identify a previous HDE similar to
one they are planning or have recently conducted and use data
from these experiments to construct plasmode data sets with which
to evaluate candidate statistical methods. This will enable
investigators to choose the most appropriate method(s) for
analyzing their own data and thus to increase the reliability of
their research results. In this manner, statistical science (as a
discipline that studies the methods of statistics) becomes as much
an empirical science as a theoretical one.
Methods
The quantities in Table 1 are those for a typical microarray
experiment. Let N=A+B and M=C+D and note that both N and
M will be known and K=N+M. However, the number of false
discoveries is equal to an unknown number C. The proportion of
false discoveries for this experiment is C/M. Benjamini
and Hochberg [6] defined FDR as,
FDR~E C=M I Mw0 fg
hi
~E C=M Mw0 j
hi
P(M.0) where
I{M.0} is an indicator function equal to 1 if M.0 and zero
otherwise. Storey [12] defined the positive FDR as
pFDR~E C=M Mw0 j
hi
. Since P(M.0)$12(12t)
K, and since K
is usually very large, FDR<pFDR, so we do not distinguish
between FDR and pFDR as the parameter being estimated and
simply refer to it as FDR with estimates denoted d FDR FDR (and
d LFDR LFDR).
Suppose we identify a template data set corresponding to a two
treatment comparison for differential gene expression for K genes.
Obtain a vector, d, of effect sizes. One suggestion is the usual t-
statistic, where the i
th component of d, is given by
di~
  X Xi,trt{  X Xi,ctrl
SPi
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
ntrt z 1
nctrl
q ð5Þ
where ntrt, nctrl are number of biological replicates in the treatment
and control group, respectively, X ¯ i,trt, X ¯ i,ctrl are the mean gene
expression levels for gene i in treatment and control groups, and
SP2
i ~
ni,trt{1 ðÞ S2
i,trtz ni,ctrl{1 ðÞ S2
i,ctrl
ni,trtzni,ctrl{2 , is the usual pooled sample variance
for the ith gene, where the two sample variances are given by S2
i,trt,
S2
i,ctrl. In what follows, we will use this choice for di since it allows
for effects to be described by a unitless quantity, i.e., it is scaled by
the standard error of the observed mean difference X ¯ i,trt2X ¯ i,ctrl for
each gene.
For convenience, assume that nctrl is an even number and divide
the control group into two sets of equal size. Requiring nctrl$4
allows for at least two arrays in each set, thus allowing estimates of
variance within each of the two sets. This will be the basis for the
plasmode ‘‘null’’ data set. There are
nctrl
nctrl=2
  
ways of making
this division. Without loss of generality, assume that the first nctrl/2
arrays after the division are the plasmode control group and the
second nctrl/2 are the plasmode treatment group. Specify a value of
p0 and specify a threshold, t, such that a P-value #t is declared
evidence of differential expression. Execute the following steps.
1) Sample without replacement (12p0)K (rounding down to the
nearest integer) from the integers 1,…, K. Denote this set as
S
*. This set will denote those genes that will be differentially
expressed.
2) Sample (12p0)K (rounding down) effect sizes without
replacement from the vector d with components given by
equation (5), where the ith component is selected with a
weighted probability,
di jj P
di jj . Denote this vector as d
*. This
will be the set of effect sizes used to differentially express
genes. The weighted probability sampling allows for the fact
that the original vector d contains effects for both
differentially expressed genes and genes corresponding to
true null hypotheses. Thus larger effects are more likely to be
selected, but the chance remains for very small effects to be
selected as well. The weighted probabilities could be
modified to allow for a higher (or lower) probability of large
effects being sampled and, as such, could be a tuning
adjustment in a plasmode simulation procedure.
3) For each expression level in the plasmode treatment group
and for each gene, j, in the set S
*, add the amount d
 
j :Sj,ctrl
where Sj,ctrl is the sample standard deviation for the jth gene
in the original control group. This is one plasmode data set
with a null reference data set obtained within the control
group but effect sizes borrowed from the full microarray
experiment.
4) Conduct a statistical test for differentially expressed genes on
the plasmode data set and record the distribution of P-
values. Determine which genes have P-values #t.
5) Note that p0 and the set S
* are known, so a true value of
FDR for this data set is available. This true value will change
with each simulated data set since the set S
* and the vector
d
* will be different in each simulation.
6) Apply a statistical method that estimates p0, FDR, LFDR
and other quantities of interest. Estimates of FDR and
LFDR are computed at a preset threshold t. Some methods
compute these estimates at the observed P-values in which
case we interpolate the estimates computed at the two
nearest P-values above and below t.
7) Repeat steps 1–6 B times. Record summary statistics such as
the mean, standard deviation, and range of the true FDR
over the B plasmodes, and the summary statistics from the
estimates obtained from the statistical method that is being
evaluated.
8) Choose another threshold t and/or another value of p0 and
repeat for a new simulation case.
One can then obtain another data set and repeat the entire
process to evaluate a method on a different type of data, perhaps
from a different organism having a different null distribution, or a
different treatment type giving a different distribution of effect
sizes, d. Alternatively, one might choose to randomly divide the
control group again and repeat the entire process. This would help
assess how differences in arrays within a group or possible
correlation structure might affect results from a method. If some of
the arrays in the control group have systematic differences among
Evaluating Methods with Plasmodes
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conditions—day, operator, technology, etc.), then the null
distribution can be sensitive to the random division of the original
control group into the two plasmode groups, particularly if nctrl is
small.
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